USPTO serial 78378648
INNUREX
Reviewed by CopyMark Law Group
- Filing date
- Status date
- Registration date
- May 20, 2008
- Examiner
- ALI, STEPHANIE MARIE
- Law office
- POST REGISTRATION
What this means
Status 710 means the registration was cancelled because a required Section 8 declaration of continued use was not filed within the deadline (including any grace period). The federal registration is no longer active. Evaluate filing a new application if you still use the mark, or petition if cancellation was erroneous. Consult counsel on remaining common-law rights.
Need help with INNUREX?
If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.
Owner
Attorney of record
The USPTO lists this attorney as the applicant's representative for correspondence on this application.
Purvi J. Patel
Purvi J. Patel Haynes and Boone, LLP2323 Victory Avenue, Suite 700Dallas, TX 75219-7673UNITED STATESGoods and services
| Class | Description | Status | First use |
|---|---|---|---|
| 001 | Chemical and biochemical products for use in gene delivery technology, enzymes and chemicals for in vitro use in laboratories and for analysis in gene delivery technology, enzymes and chemicals for in vitro use in laboratories and for analysis in gene delivery technology, micro-organisms, cell cultures, plasmids and cultures of micro-organisms, deoxyribonucleic acid sequences, cloning vehicles and recombinant deoxyribonucleic variations thereof, all for in vivo use in gene delivery technology and catalysts for gene delivery technology in the fields of disease and injury of the nervous system, including spinal cord injury and disease and peripheral nerve injury and disease | SECTION 8 - CANCELLED | — |
| 005 | Gene therapy and prophylaxis products, pharmaceutical substances and preparations for use in the medical industry, namely, vaccines, enzymes and enzyme preparations, anti-apoptopic and angiostatic/angiogenic molecules, retroviral vector and retroviral vector manufacturing preparations, all for use in gene delivery technologies in the fields of disease and injury of the nervous system, including spinal cord injury and disease and peripheral nerve injury and disease; vector production technologies and neurogenomics products in the fields of disease and injury of the nervous system, including spinal cord injury and disease and peripheral nerve injury and disease; Chemical products for use in medical science for the treatment of diseases of the eye, vascular and neo-vascularisition disorders, single gene disorders, cancer, diseases of the nervous system, inflammatory and auto-immune diseases, blood disorders, vascular disorders and disorders arising from inappropriate vascularisation *and injuries of the nervous, system all* in the fields of disease and injury of the nervous system, including spinal cord injury and disease and peripheral nerve injury and disease; pharmaceutical and biochemical preparations for the treatment of damaged nerves and spinal injuries and for the induction of nerve re-growth; medical instruments and apparatus for the administration of gene and antibody-based therapy and prophylactics, preparations and substances, namely, pre-filled vials, syringes and injectors for medical purposes, all in the fields of disease and injury of the nervous system, including spinal cord injury and disease and peripheral nerve injury and disease | SECTION 8 - CANCELLED | — |
Related trademarks
CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.
- Other trademarks owned by Oxford BioMedica plc
- Other trademarks owned by Oxford BioMedica plc
- Other trademarks owned by Oxford BioMedica plc
- Other trademarks in Class 001
- Other trademarks in Class 005
- Similar marks named INNUREX
- Recently changed USPTO trademarks
- Recently filed trademarks
- Browse all trademark records
Prosecution history
| Date | Code | Event | What it means |
|---|---|---|---|
| Dec 26, 2014 | C8.. | CANCELLED SEC. 8 (6-YR) | — |
| Jun 1, 2009 | COC. | CORRECTION UNDER SECTION 7 - PROCESSED | — |
| Jan 6, 2009 | PLGL | ASSIGNED TO PARALEGAL | — |
| Dec 17, 2008 | TCCA | TEAS CHANGE OF CORRESPONDENCE RECEIVED | — |
| Dec 17, 2008 | TCCA | TEAS CHANGE OF CORRESPONDENCE RECEIVED | — |
| Dec 9, 2008 | ES7R | TEAS SECTION 7 REQUEST RECEIVED | — |
| Sep 15, 2008 | COC. | CORRECTION UNDER SECTION 7 - PROCESSED | — |
| Sep 15, 2008 | PLGL | ASSIGNED TO PARALEGAL | — |
| May 20, 2008 | R.PR | REGISTERED-PRINCIPAL REGISTER | Your trademark is registered on the Principal Register — the strongest form of federal trademark protection. You may use the ® symbol for the covered goods and services. Maintenance filings (Section 8 and renewals) are required to keep the registration alive. |
| Apr 16, 2008 | TMBN | TTAB RELEASE CASE TO TRADEMARKS | — |
| Apr 16, 2008 | OP.T | OPPOSITION TERMINATED NO. 999999 | — |
| Apr 16, 2008 | OP.D | OPPOSITION DISMISSED NO. 999999 | — |
| Mar 4, 2008 | PAPER RECEIVED | — | |
| Mar 9, 2006 | OP.I | OPPOSITION INSTITUTED NO. 999999 | — |
| Dec 8, 2005 | ETOF | EXTENSION OF TIME TO OPPOSE RECEIVED | — |
| Nov 8, 2005 | PUBO | PUBLISHED FOR OPPOSITION | Your mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance. |
| Oct 19, 2005 | NPUB | NOTICE OF PUBLICATION | — |
| Sep 22, 2005 | PREV | LAW OFFICE PUBLICATION REVIEW COMPLETED | — |
| Sep 16, 2005 | ALIE | ASSIGNED TO LIE | — |
| Sep 13, 2005 | CNSA | APPROVED FOR PUB - PRINCIPAL REGISTER | — |
| Sep 13, 2005 | XAEC | EXAMINER'S AMENDMENT ENTERED | — |
| Sep 13, 2005 | CNEA | EXAMINERS AMENDMENT MAILED | — |
| Sep 13, 2005 | CNEA | EXAMINERS AMENDMENT -WRITTEN | — |
| Sep 9, 2005 | ZZZX | PREVIOUS ALLOWANCE COUNT WITHDRAWN | — |
| Aug 22, 2005 | CWBP | WITHDRAWN BEFORE PUBLICATION | — |
| May 24, 2005 | PREV | LAW OFFICE PUBLICATION REVIEW COMPLETED | — |
| May 20, 2005 | ALIE | ASSIGNED TO LIE | — |
| May 17, 2005 | CNSA | APPROVED FOR PUB - PRINCIPAL REGISTER | — |
| Mar 23, 2005 | TEME | TEAS/EMAIL CORRESPONDENCE ENTERED | — |
| Mar 16, 2005 | CRFA | CORRESPONDENCE RECEIVED IN LAW OFFICE | — |
| Mar 16, 2005 | TROA | TEAS RESPONSE TO OFFICE ACTION RECEIVED | This event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action. |
| Sep 22, 2004 | CNRT | NON-FINAL ACTION MAILED | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Sep 21, 2004 | CNRT | NON-FINAL ACTION WRITTEN | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Sep 20, 2004 | DOCK | ASSIGNED TO EXAMINER | — |
| Mar 19, 2004 | NWAP | NEW APPLICATION ENTERED | — |